Opaleye Management Inc.

CIK 1595855 · last filed 2026-10-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$314.64M
Companies
14
Total Filings
227
Lifetime Open-Market Net
$33.25M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

ETON price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
ONE BOSTON PLACE
SUITE 2600
BOSTON, MA 02108
Phone
(617) 904-9195
State of Incorporation
MA
Related Filers
HARROW HEALTH, INC. — 57 joint filings, latest 2026-07-31
SANUWAVE Health, Inc. — 14 joint filings, latest 2026-07-31
Cerecor Inc. — 3 joint filings, latest 2020-02-14
Fortress Biotech, Inc. — 3 joint filings, latest 2021-02-12
Recro Pharma, Inc. — 2 joint filings, latest 2015-02-13
BERKSHIRE FUND V L P — same reported address
BERKSHIRE FUND VII-A L P — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GRCE 10%+ Owner 2,948,610 $1.84 $5.42M $433.6K 9 2026-10-21
ACOG 10%+ Owner 3,259,894 $8.83 $28.78M $7.90M 23 2026-10-19
SLGL 10%+ Owner 538,507 $70.50 $37.97M $11.23M 25 2026-09-14
ETON 10%+ Owner 2,665,000 $49.86 $132.88M -$13.95M 17 2026-07-17
SNWV 10%+ Owner 5,000 $5.16 $25.8K -$669.0K 4 2026-05-04
HROW 10%+ Owner 3,756,000 $28.68 $107.72M -$6.77M 9 2026-03-05
CDXS 10%+ Owner 179,989 $1.29 $232.2K $11.11M 28 2025-12-15
HARROW, INC. (HROWM) Delisted 10%+ Owner 90,000 $26.03 $2.34M -$571.8K 16 2025-06-11
TARA 10%+ Owner 51,500 $2.37 $122.1K $5.07M 24 2024-09-12
Tracon Pharmaceuticals, Inc. (TCON) Delisted 10%+ Owner 0 $0.03 $0 $7.74M 36 2023-11-14
TELA 10%+ Owner 124,813 $0.99 $123.6K $3.99M 19 2023-04-20
HARROW, INC. (HROWL) Delisted 10%+ Owner 3,600,000 $25.61 $92.20M $6.80M 8 2022-12-14
OCUL 10%+ Owner 207,500 $6.62 $1.37M $137.9K 3 2020-04-03
HARROW, INC. (IMMY) Delisted 10%+ Owner 1,250,000 — — $789.4K 5 2016-03-14

Recent Filings · Page 12 of 23

227 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-09-10 TARA Sell (S) −61,992 -$114.3K EDGAR
2024-07-18 TARA Sell (S) −11,396 -$27.8K EDGAR
2024-07-11 TARA Sell (S) −74,551 -$175.8K EDGAR
2024-07-03 TARA Sell (S) −8,288 -$17.6K EDGAR
2024-06-28 TARA Sell (S) −64,568 -$142.5K EDGAR
2024-06-27 TARA Sell (S) −12,725 -$28.7K EDGAR
2024-05-31 TARA Sell (S) −15,054 -$44.0K EDGAR
2024-05-23 TARA Sell (S) −42,800 -$130.4K EDGAR
2024-05-17 TARA Sell (S) −70,885 -$230.3K EDGAR
2024-05-10 TARA Sell (S) −182,300 -$567.0K EDGAR
Showing 111–120 of 227
Page 12 of 23
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.